Hospital
Jackson County Memorial Hospital Authority
Jackson County Memorial Hospital Authority was paid $9.01M by Medicaid between Jan 2018 and Nov 2024, across 113 billing codes. Its largest line is 99283, emergency room visit (moderate) — 32% of everything it billed.
33Billing provider infoJACKSON COUNTY MEMORIAL HOSPITAL AUTHORITY
ALTUS, OK 73521
ALTUS, OK 73521
33aNPI1093763781assigned 05/04/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.01M
24GClaims144,568
24DCodes billed113
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Oklahoma
Rank by total paid#15 of 75
Median peer was paid$3.66M
This provider vs. median2.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,749 | $971K | |
| 2019 | 17,407 | $999K | |
| 2020 | 12,936 | $742K | |
| 2021 | 18,848 | $1.41M | |
| 2022 | 29,104 | $2.00M | |
| 2023 | 33,211 | $2.06M | |
| 2024incomplete | 14,313 | $826K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 32% | 28,166 | 19,208 | $2.91M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 29% | 16,367 | 12,803 | $2.59M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14% | 5,536 | 4,246 | $1.30M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.0% | 3,173 | 3,156 | $274K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.8% | 3,449 | 2,552 | $255K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.3% | 1,637 | 1,598 | $205K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.5% | 2,683 | 2,536 | $135K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.2% | 800 | 779 | $109K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.2% | 1,529 | 393 | $105K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 6,086 | 5,874 | $96K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 552 | 542 | $75K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,300 | 5,161 | $74K |
101 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 427 | $57K |
| 80053 | Comprehensive metabolic panel | <1% | 4,635 | $51K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,893 | $49K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,726 | $48K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 447 | $46K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,738 | $45K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 596 | $45K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 525 | $29K |
| 87070 | <1% | 3,551 | $28K | |
| 87480 | <1% | 1,520 | $28K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,304 | $26K |
| 87510 | <1% | 1,520 | $24K | |
| 87660 | <1% | 1,512 | $24K | |
| 99223 | Prolong inpt eval add15 m | <1% | 264 | $23K |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,197 | $23K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 483 | $21K |
| 81003 | <1% | 9,673 | $20K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 644 | $20K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 290 | $19K |
| 87807 | <1% | 1,673 | $19K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 378 | $17K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 266 | $15K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 298 | $14K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 403 | $13K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 287 | $13K |
| 81001 | <1% | 3,703 | $11K | |
| 87428 | <1% | 366 | $10K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 666 | $10K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,306 | $9K |
| 99460 | <1% | 95 | $9K | |
| 86780 | <1% | 742 | $8K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,243 | $7K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 122 | $6K |
| 86850 | <1% | 584 | $5K | |
| 83655 | <1% | 400 | $4K | |
| 88341 | <1% | 12 | $4K | |
| 86803 | <1% | 362 | $4K | |
| 84703 | <1% | 636 | $4K | |
| 20610 | <1% | 119 | $4K | |
| 80055 | <1% | 102 | $4K | |
| 87430 | <1% | 303 | $4K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 57 | $4K |
| 86787 | <1% | 324 | $4K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 101 | $4K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 53 | $3K |
| 86703 | <1% | 321 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 46 | $2K |
| 86762 | <1% | 190 | $2K | |
| 84481 | <1% | 151 | $2K | |
| 84439 | <1% | 270 | $2K | |
| 80061 | Lipid panel | <1% | 186 | $2K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 83 | $2K |
| 86900 | <1% | 572 | $2K | |
| 87340 | <1% | 203 | $2K | |
| 85027 | <1% | 333 | $2K | |
| 87420 | <1% | 130 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 28 | $2K |
| 96127 | <1% | 329 | $1K | |
| 86901 | <1% | 584 | $1K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 13 | $1K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 381 | $1K |
| 99220 | <1% | 14 | $1K | |
| 85660 | <1% | 251 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 25 | $1K |
| 80050 | General health panel | <1% | 12 | $964.83 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 121 | $861.95 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 117 | $859.36 |
| 82247 | <1% | 169 | $853.80 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 27 | $762.93 |
| 94060 | <1% | 67 | $761.79 | |
| 83605 | <1% | 65 | $729.53 | |
| 85018 | <1% | 323 | $683.47 | |
| 82248 | <1% | 170 | $652.65 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 71 | $593.22 |
| 83721 | <1% | 65 | $568.28 | |
| 84484 | <1% | 50 | $554.50 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 153 | $550.11 |
| 88342 | <1% | 12 | $528.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 14 | $498.13 |
| 80306 | <1% | 34 | $488.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 33 | $473.94 |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 12 | $452.45 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 27 | $451.65 |
| 86592 | <1% | 118 | $439.15 | |
| 82947 | <1% | 128 | $430.70 | |
| 73562 | <1% | 12 | $369.13 | |
| 84702 | <1% | 28 | $348.14 | |
| 83690 | <1% | 58 | $342.31 | |
| 51798 | <1% | 57 | $307.00 | |
| 85049 | <1% | 73 | $279.13 | |
| 99307 | <1% | 27 | $249.63 | |
| 85014 | <1% | 111 | $232.71 | |
| 81015 | <1% | 41 | $111.11 | |
| 83735 | <1% | 12 | $67.24 | |
| 82962 | <1% | 29 | $58.40 | |
| 82950 | <1% | 12 | $46.53 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 91 | $33.52 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 230 | $0.16 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 27 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 26 | $0.00 |
| J3490 | Unclassified drugs | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARTGRAVES, STEVE (PRESIDENT CEO)
| Provider | Location | Paid |
|---|---|---|
| Jackson County Memorial Hospital Authority | Altus, OK | $4.19M |
| Jackson County Memorial Hospital Authority | Altus, OK | $2.97M |
| Jackson County Memorial Hospital Authority | Altus, OK | $2.90M |
| Jackson County Memorial Hospital Authority | Mangum, OK | $621K |
| Jackson County Memorial Hospital Authority | Hollis, OK | $290K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.